These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33415428)

  • 1. Doping practices in international weightlifting: analysis of sanctioned athletes/support personnel from 2008 to 2019 and retesting of samples from the 2008 and 2012 Olympic Games.
    Kolliari-Turner A; Oliver B; Lima G; Mills JP; Wang G; Pitsiladis Y; Guppy FM
    Sports Med Open; 2021 Jan; 7(1):4. PubMed ID: 33415428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Anti-Doping Rule Violations That Have Impacted Medal Results at the Summer Olympic Games 1968-2012.
    Kolliari-Turner A; Lima G; Hamilton B; Pitsiladis Y; Guppy FM
    Sports Med; 2021 Oct; 51(10):2221-2229. PubMed ID: 33835351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between Doping Prevalence and Socioeconomic Parameters: An Analysis by Sport Categories and World Areas.
    Terreros JL; Manonelles P; López-Plaza D
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35954686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H; Auchus RJ
    Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of anti-doping measures on sports performance in weightlifting.
    Bezuglov E; Malyakin G; Telyshev D; Morgans R; Lazarev A; Kapralova E; Sadkovaya O; Talibov O
    J Sports Sci; 2024 Feb; 42(4):373-380. PubMed ID: 38531055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ten-year assessment of anabolic steroid misuse among competitive athletes in Puerto Rico.
    Acevedo P; Jorge JC; Cruz-Sánchez A; Amy E; Barreto-Estrada JL
    West Indian Med J; 2011 Oct; 60(5):531-5. PubMed ID: 22519228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug testing at the 10th Asian Games and 24th Seoul Olympic Games.
    Park J; Park S; Lho D; Choo HP; Chung B; Yoon C; Min H; Choi MJ
    J Anal Toxicol; 1990; 14(2):66-72. PubMed ID: 2325381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of weightlifting performance analysis in anti-doping.
    Ryoo H; Ryu S; Kim D; Jeong H; Eun D; Suh SH
    PLoS One; 2022; 17(2):e0263398. PubMed ID: 35120152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial features and unethical behavior - Doped athletes show higher facial width-to-height ratios than non-doping sanctioned athletes.
    Krenn B; Buehler C
    PLoS One; 2019; 14(10):e0224472. PubMed ID: 31665155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of doping suspicions through artificial intelligence-powered analysis on athlete's performance passport in female weightlifting.
    Ryoo H; Cho S; Oh T; Kim Y; Suh SH
    Front Physiol; 2024; 15():1344340. PubMed ID: 38938745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood doping at the Olympic Games.
    Fitch KD
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping control analysis at the Rio 2016 Olympic and Paralympic Games.
    Pereira HMG; Sardela VF; Padilha MC; Mirotti L; Casilli A; de Oliveira FA; de Albuquerque Cavalcanti G; Rodrigues LML; de Araujo ALD; Levy RS; Teixeira PAC; de Oliveira FAG; Duarte ACG; Carneiro ACD; Evaristo JAM; Dos Santos GRC; da Costa GCV; de Lima Castro F; Nogueira FCS; Scalco FB; Pizzatti L; de Aquino Neto FR
    Drug Test Anal; 2017 Nov; 9(11-12):1658-1672. PubMed ID: 29078043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intelligence-based doping control planning improves testing effectiveness: Perspectives from a national anti-doping organisation.
    Lauritzen F; Holden G
    Drug Test Anal; 2023 May; 15(5):506-515. PubMed ID: 36582051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doping in Paralympic sport: perceptions, responsibility and anti-doping education experiences from the perspective of Paralympic athletes and parasport coaches.
    Blank C; Weber K; Boardley ID; Abel T; Schobersberger W; Patterson LB
    Front Sports Act Living; 2023; 5():1166139. PubMed ID: 37483282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-doping analyses at the Sochi Olympic and Paralympic Games 2014.
    Sobolevsky T; Krotov G; Dikunets M; Nikitina M; Mochalova E; Rodchenkov G
    Drug Test Anal; 2014; 6(11-12):1087-101. PubMed ID: 25312500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.